Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for minimal hepatic encephalopathy
2007-007117-36Phase 4Completed
- Sponsor
- Lourdes Grande Santamaria
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rifaximin in hepatic encephalopathy (HE) (2 arms), sponsored by Lourdes Grande Santamaria. Primary endpoint: Minimal hepatic encephalopathy. Started Feb 2008; status: completed.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on 2007-007117-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007117-36.